Repro Med Systems, Inc. (KRMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
KORU Medical Systems Announces 2020 First Quarter Financial Results
May 4, 2020 4:52 PM EDTQ1 2020 Summary
Net sales rose 27% to $6.3 million Gross margin of 60% (62% excluding inventory obsolescence charge) Net income improved to $0.4 million, or $0.01 per share Adjusted EBITDA increased 38% to $1.3 million COVID-19 UpdateCHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company) today announced financial results for the first quarter ended March 31, 2020 (Q1 2020).
We reported a strong Q1 2020 with net sales, net income, and Adjusted EBITDA rising from Q1 2019, said Don Pettigrew, President and CEO. We... More



